Werner Scheithauer
Department of Internal Medicine I
Division of Oncology
Vienna University Medical School
Vienna
Name/email consistency: high
- Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer. Scheithauer, W., Kornek, G.V., Raderer, M., Schüll, B., Schmid, K., Kovats, E., Schneeweiss, B., Lang, F., Lenauer, A., Depisch, D. J. Clin. Oncol. (2003)
- Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial. Scheithauer, W., McKendrick, J., Begbie, S., Borner, M., Burns, W.I., Burris, H.A., Cassidy, J., Jodrell, D., Koralewski, P., Levine, E.L., Marschner, N., Maroun, J., Garcia-Alfonso, P., Tujakowski, J., Van Hazel, G., Wong, A., Zaluski, J., Twelves, C. Ann. Oncol. (2003)
- Randomized multicenter phase II trial of oxaliplatin plus irinotecan versus raltitrexed as first-line treatment in advanced colorectal cancer. Scheithauer, W., Kornek, G.V., Raderer, M., Ulrich-Pur, H., Fiebiger, W., Gedlicka, C., Schüll, B., Brugger, S., Schneeweiss, B., Lang, F., Lenauer, A., Depisch, D. J. Clin. Oncol. (2002)
- Intermittent weekly high-dose capecitabine in combination with oxaliplatin: a phase I/II study in first-line treatment of patients with advanced colorectal cancer. Scheithauer, W., Kornek, G.V., Raderer, M., Schüll, B., Schmid, K., Längle, F., Huber, H. Ann. Oncol. (2002)
- Treatment of advanced breast cancer with vinorelbine and docetaxel with or without human granulocyte colony-stimulating factor. Kornek, G.V., Ulrich-Pur, H., Penz, M., Haider, K., Kwasny, W., Depisch, D., Kovats, E., Lang, F., Schneeweiss, B., Scheithauer, W. J. Clin. Oncol. (2001)
- Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma: results of a Phase I-II trial. Scheithauer, W., Kornek, G.V., Ulrich-Pur, H., Penz, M., Raderer, M., Salek, T., Haider, K., Kwasny, W., Depisch, D. Cancer (2001)
- Second-line treatment with oxaliplatin + raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapy. Scheithauer, W., Kornek, G.V., Schuell, B., Ulrich-Pur, H., Penz, M., Raderer, M., Lang, F., Schneeweiss, B., Lenauer, A., Depisch, D. Ann. Oncol. (2001)